-
201
Late-onset and relapsed cytokine release syndrome after nivolumab treatment in a patient with head and neck squamous cell carcinoma: a case report
Published 2025-02-01Subjects: “…head and neck squamous cell carcinoma…”
Get full text
Article -
202
MTMR6 downregulation contributes to cisplatin resistance in oral squamous cell carcinoma
Published 2025-01-01Subjects: “…Oral squamous cell carcinoma…”
Get full text
Article -
203
miR‐130a‐3p regulated TGF‐β1‐induced epithelial‐mesenchymal transition depends on SMAD4 in EC‐1 cells
Published 2019-03-01Subjects: Get full text
Article -
204
PER3 suppresses tumor metastasis of oral squamous cell carcinoma by promoting HIF-1α degradation
Published 2025-02-01Subjects: “…Oral squamous cell carcinoma…”
Get full text
Article -
205
In vivo antitumor activity of PHT-427 inhibitor-loaded polymeric nanoparticles in head and neck squamous cell carcinoma
Published 2025-12-01Subjects: “…hypopharyngeal squamous cell carcinoma…”
Get full text
Article -
206
Non-melanoma skin cancer treated with hypofractionated 192—Ir contact brachitherapy: a single institution series
Published 2025-01-01Subjects: Get full text
Article -
207
Constructing individualized follow-up strategies for locally advanced esophageal squamous cell carcinoma patients based on dynamic recurrence risk changes
Published 2025-01-01Subjects: “…Locally advanced esophageal squamous cell carcinoma…”
Get full text
Article -
208
Case report: Multi-organ injuries induced by tislelizumab
Published 2025-02-01Subjects: “…lung squamous cell carcinoma…”
Get full text
Article -
209
CircCCT2/miR-146a-5p/IRAK1 axis promotes the development of head and neck squamous cell carcinoma
Published 2025-01-01Subjects: “…Head and neck squamous cell carcinoma…”
Get full text
Article -
210
Catalysts of change: Immunotherapy's frontier in oral oncology
Published 2024-09-01Subjects: “…Head and neck squamous cell carcinoma (HNSCC)…”
Get full text
Article -
211
The systemic oxidative stress index predicts clinical outcomes of esophageal squamous cell carcinoma receiving neoadjuvant immunochemotherapy
Published 2025-01-01Subjects: Get full text
Article -
212
Deletion of cyclin dependent kinase inhibitor 2a gene as a marker of oropharyngeal carcinomas non-associated with human papillomavirus and its prognostic value
Published 2024-06-01Subjects: “…squamous cell carcinoma…”
Get full text
Article -
213
Donor site scar preference in head and neck free flap reconstruction: The patient point of view
Published 2024-06-01Subjects: Get full text
Article -
214
-
215
The necroptosis-related lncRNA ENSG00000253385.1 promotes the progression of esophageal squamous cell carcinoma by targeting the miR-16-2-3p/VDAC1 axis
Published 2025-01-01Subjects: “…Esophageal squamous cell carcinoma…”
Get full text
Article -
216
Identification of novel therapeutic targets for head and neck squamous cell carcinoma through bioinformatics analysis
Published 2024-12-01Subjects: “…Head and neck squamous cell carcinoma…”
Get full text
Article -
217
Drug delivery systems for oral cancer treatment: A patent perspective
Published 2024-03-01Subjects: Get full text
Article -
218
Efficacy and safety of immunotherapy for head and neck squamous cell carcinoma: a meta-analysis of randomized clinical trials
Published 2025-01-01Subjects: Get full text
Article -
219
Insights into expression and localization of HPV16 LCR-associated transcription factors and association with LCR activity in HNSCC
Published 2025-03-01Subjects: “…head and neck squamous cell carcinoma, HNSCC…”
Get full text
Article -
220
Global, regional, national prevalence, mortality, and disability-adjusted life-years of cutaneous squamous cell carcinoma and trend analysis from 1990 to 2021 and prediction to 204...
Published 2025-02-01Subjects: “…cutaneous squamous cell carcinoma…”
Get full text
Article